Kezar Life Sciences Inc.

NASDAQ: KZR · Real-Time Price · USD
3.97
-0.01 (-0.25%)
At close: Aug 15, 2025, 3:59 PM
3.97
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kezar Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 7M n/a n/a
Cost of Revenue
1.04M 1.07M 1.02M 1.51M
Gross Profit
-1.04M 5.93M -1.02M -1.51M
Operating Income
-90.61M -105.24M -71.16M -54.66M
Interest Income
8.46M 11.1M 4.11M 188K
Pretax Income
-83.74M -101.87M -68.24M -54.63M
Net Income
-83.74M -101.87M -68.24M -54.63M
Selling & General & Admin
23.39M 26.54M 20.15M 15.72M
Research & Development
65.74M 85.7M 51.01M 38.94M
Other Expenses
1.47M -70.9M -44.4M -1.51M
Operating Expenses
90.61M 41.34M 26.77M 53.15M
Interest Expense
1.59M 1.55M 1.19M 159K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
90.61M 118.42M 71.16M 54.66M
Income Tax Expense
n/a n/a -79K -1.35M
Shares Outstanding (Basic)
72.9M 72.55M 67.37M 52.76M
Shares Outstanding (Diluted)
72.9M 72.55M 67.37M 52.76M
EPS (Basic)
-1.15 -1.4 -1.01 -1.04
EPS (Diluted)
-1.15 -1.4 -1.01 -1.04
EBITDA
-81.1M -99.25M -66.11M -52.96M
EBIT
-82.14M -100.32M -67.13M -54.47M
Depreciation & Amortization
1.04M 1.07M 1.02M 1.51M